CD8A and hepatocellular carcinoma: For example, EV-circRNA can be taken up by CD8 + T cells, leading to CD8 + T cell dysfunction by stabilizing the PD-1 protein, thus promoting immune evasion and resistance to anti-PD-1 immunotherapy in HCC [158].